Spiky Tumor Structures Identified as Key Driver of Cancer Metastasis
Scientists discovered that aggressive breast and melanoma tumors have spiky structures that facilitate cancer spread, potentially leading to new treatments that prevent metastasis by targeting these spikes.
Spiky Tumor Structures Identified as Key Driver of Cancer Metastasis
Scientists discovered that aggressive breast and melanoma tumors have spiky structures that facilitate cancer spread, potentially leading to new treatments that prevent metastasis by targeting these spikes.
Progress
40% Bias Score
Mother of Four Battles Stage 4 Melanoma After Delayed Diagnosis
Kelly Heather, 38, from Kent, UK, is battling stage 4 metastatic melanoma after a dark line on her fingernail, initially dismissed, proved to be aggressive skin cancer that spread to her brain; her case highlights the importance of early detection and persistent advocacy for additional testing in ca...
Mother of Four Battles Stage 4 Melanoma After Delayed Diagnosis
Kelly Heather, 38, from Kent, UK, is battling stage 4 metastatic melanoma after a dark line on her fingernail, initially dismissed, proved to be aggressive skin cancer that spread to her brain; her case highlights the importance of early detection and persistent advocacy for additional testing in ca...
Progress
48% Bias Score
Oncolytic Virus Immunotherapy Shows Promise for Advanced Melanoma
In a phase 2 clinical trial, combining the oncolytic virus immunotherapy RP1 with nivolumab resulted in a 30% overall response rate and 15% complete response rate in 140 patients with advanced melanoma unresponsive to prior immunotherapy, leading to FDA Breakthrough Therapy designation.
Oncolytic Virus Immunotherapy Shows Promise for Advanced Melanoma
In a phase 2 clinical trial, combining the oncolytic virus immunotherapy RP1 with nivolumab resulted in a 30% overall response rate and 15% complete response rate in 140 patients with advanced melanoma unresponsive to prior immunotherapy, leading to FDA Breakthrough Therapy designation.
Progress
48% Bias Score
Russia to Launch Personalized mRNA Cancer Vaccine in September 2025
Russia will introduce a personalized mRNA cancer vaccine for melanoma and some leukemia patients in September 2025, developed by the Gamaleya Research Institute with funding from President Putin; initial trials show promise.
Russia to Launch Personalized mRNA Cancer Vaccine in September 2025
Russia will introduce a personalized mRNA cancer vaccine for melanoma and some leukemia patients in September 2025, developed by the Gamaleya Research Institute with funding from President Putin; initial trials show promise.
Progress
64% Bias Score
Australia's Declining Melanoma Risk in Youth Threatened by Social Media
Australia's melanoma rates, while high, show a decreased risk in younger people since the 1990s, countered by a new social media trend promoting tanning, prompting a new sun safety campaign.
Australia's Declining Melanoma Risk in Youth Threatened by Social Media
Australia's melanoma rates, while high, show a decreased risk in younger people since the 1990s, countered by a new social media trend promoting tanning, prompting a new sun safety campaign.
Progress
40% Bias Score
Gamaleya Institute's mRNA Cancer Vaccine Shows Promise in Preclinical Trials
Preclinical trials of Gamaleya Research Institute's mRNA melanoma vaccine show tumor and metastasis regression in animals; human trials are planned for autumn 2025, initially combining the vaccine with other therapies for advanced cancers; future development aims for personalized, affordable vaccine...
Gamaleya Institute's mRNA Cancer Vaccine Shows Promise in Preclinical Trials
Preclinical trials of Gamaleya Research Institute's mRNA melanoma vaccine show tumor and metastasis regression in animals; human trials are planned for autumn 2025, initially combining the vaccine with other therapies for advanced cancers; future development aims for personalized, affordable vaccine...
Progress
56% Bias Score